In mature B ceils, signals transduced through membrane immunoglobulin (Ig) produce cellular activation, yet the same receptor can also mediate deletion and silencing ofautoreactive B ceils. In addition, Ig expression during the antigen-independent phase of B cell development regulates the precursor B (pre-B) ceil transition and allelic exclusion. To account for the diverse regulatory functions induced by membrane Ig, it has been proposed that individual receptor components have independent physiologic activities. Here we establish a role for Igcx in the pre-B cell transition and allelic exclusion. We find that the cytoplasmic domain oflg~ contains sufficient information to trigger both of these antigen-independent events. Direct comparisons of the cytoplasmic domains of Igor and lg[3 show that the two are indistinguishable in the induction of the pre-B cell transition and ailelic exclusion. Our experiments suggest that, despite the reported differences in certain biochemical assays, Ig0t and Ig[3 have redundant functions in the developing B cell.
Summary
In mature B ceils, signals transduced through membrane immunoglobulin (Ig) produce cellular activation, yet the same receptor can also mediate deletion and silencing ofautoreactive B ceils. In addition, Ig expression during the antigen-independent phase of B cell development regulates the precursor B (pre-B) ceil transition and allelic exclusion. To account for the diverse regulatory functions induced by membrane Ig, it has been proposed that individual receptor components have independent physiologic activities. Here we establish a role for Igcx in the pre-B cell transition and allelic exclusion. We find that the cytoplasmic domain oflg~ contains sufficient information to trigger both of these antigen-independent events. Direct comparisons of the cytoplasmic domains of Igor and lg[3 show that the two are indistinguishable in the induction of the pre-B cell transition and ailelic exclusion. Our experiments suggest that, despite the reported differences in certain biochemical assays, Ig0t and Ig[3 have redundant functions in the developing B cell.
L
Ymphocyte development progresses through a series of ordered events, ultimately resulting in B and T cells that express clonotypic Ig or TC1Ks. Although the initial lineage commitment events are independent of Ig and TCR expression, many of the subsequent checkpoints in both the T and B cell pathways are regulated by these receptors. In the bone marrow, regulation of the B cell pathway by membrane Ig begins in the earliest identifiable committed B cell progenitors (pro-B ceils)? Experiments with transgenic and gene-targeted mice have shown that progression from the pro-B ceil to precursor B (pre-B) ceil stage is dependent on expression of the membrane-bound form of heavy chain (1) (2) (3) . In the pre-B ceil, be expression regulates a second checkpoint, the allelic exclusion of a second heavy chain locus (4) (5) (6) . Both the pre-B cell transition and allelic exclusion are believed to be antigen-independent events since they can occur before Ig light chain gene rearrangements, and thus before the assembly of a mature receptor Ig.
After light chain gene rearrangement and completion of cell surface receptor assembly, interactions between surface Ig and antigen largely control cell fate. Binding of self-antigens to the receptor in the newly matured B ceil can lead 1Abbreviations used in this paper: pre--B cell, precursor B cell; pro-B cell, B cell progenitor; RAG, recombinase-activating gene.
to receptor editing (7, 8) and deletion of autoreactive cells (9) (10) (11) (12) . By contrast, binding of antigens to the Ig receptor in mature B cells is one of the key elements in activating clonal expansion and antibody secretion. Thus, a single receptor has a number of apparently distinct antigen-dependent and -independent regulatory functions in the B cell pathway.
Two models have been put forward to account for these distinct activities: Either one receptor produces several qualitatively different signals, or, alternatively, similar signals are interpreted differently in different cellular contexts. Support for the first idea, that the signals are different, comes from structural and biochemical studies of the Ig receptor. The mature receptor is associated through its transmembrane domain with the two signaling molecules, Igo~ and Ig13, that form a disulfide-linked heterodimer (13) . When tested in isolation, both can activate mature B cells, but the two proteins bind to different sets of cellular kinases (14) , and several groups have found that the responses activated by Igci and Ig[3 in transfected cell lines are different (15) (16) (17) (18) .
We have recently shown that the cytoplasmic domain of Ig[3 can activate the pre-B transition and allelic exclusion in vivo by a mechanism that requires tyrosine phosphorylation (19) . Here we examine whether Igc~ can mediate these antigen-independent events, and whether lgoL and Ig[3 have different physiologic functions during early B cell development.
Materials and Methods
Constructs and Mice. Many of the heavy chain vectors used for these experiments have been described elsewhere (19) . Briefly, the starting construct for the heavy chain transgenes was a HindlIIBamHl fragment of the human ~ gene, containing the constant and membrane exons, and modified to direct the synthesis of only the membrane form of human Ix (20) . To this fragment we added a HindlII-EcoRI piece containing a murine V region (9) and murine enhancer (21) . Finally, unique BamHI and NotI sites were placed around the membrane exons for rapid replacement of the wild-type sequence with specifically modified transmembrane domains (15) (Fig. 1 A) . In addition to the wild-type heavy chain construct, we have created four others. The first construct, which we call YS :VV-IgM, differs from the wild-type in that Tyr-587 and Ser-588 of the wild-type transmembrane domain are replaced by Val. This mutation renders the molecule unable to contact endogenous Ig~ and Ig [3 (15) . The Ig~ and Ig~ cytoplasmic tails were amplified from plasmids by PCtL, and, after sequence verification, they were subcloned in frame at the end of the heavy chain transmembrane domain (15) . Flow Cytometric Analysis. The following antibodies were used for surface staining of B cells: PE-B220; FITC-CD43 ($7 hybridoma); biotin-labeled anti-human lgM (heavy chain-specific DA4.4 clone; Southern Biotechnology Associates); biotin-labeled anti-mouse K light chain (Pharmingen); and biotin-labeled antiidiotypic antibody (hybridoma 54.1 [9] ). Streptavidin-RED670 was the secondary reagent (GIBCO BILL, Gaithersburg, MD) where biotinylated antibodies were used. Data were collected on a FACSorter | and were analyzed using CellQuest software.
VDJ Recombination and Allelic Exdusion.
Ig gene rearrangements in transgenic mice were assayed by PCR as previously described (25) . Recombined sequences of VJ558L family or D region segments with J segments were amplified from bone marrow DNA from two mice for each integrant. Amplification of intervening sequences was used as DNA loading control. Primer sequences and PCR conditions were as previously described (25) . Amplified DNA was visualized by Southern hybridization with an EcolLI DNA fragment that spans the mouse J region. In this assay, the capability of a transgene to inhibit V to DJ recombination is evident as an absence of recombined VJ558L sequences. (2, 24, 26 ). An additional modification carried by all of the heavy chain genes described below was the deletion o f the first poly-A addition site, resulting in a gene that directs the synthesis o f only the membrane form o f Ig (4, 20) . Strains that carried the wild-type version of the membrane-only Ig transgenes were used as controls. Heavy and light chain gene expression was assayed by staining bone marrow cells with a panel o f mAbs (Fig. 2) . The levels of intracellular heavy and hght chain expression (Fig. 2, top and center) and cell surface idiotype expression were similar in all 10 o f the transgenic strains tested in both R A G -1 -/ -and wild-type backgrounds (Fig. 2, bottom, pro-to pre-B cell transition was assessed by staining of bone marrow cells with anti-B220 and anti-CD43 antibodies (Fig. 3) . Pro-B cells are B220+CD43 +, whereas more mature cells lose expression of CD43 and therefore become B220+CD43 -. Mice that carry complete YS:VV membrane Igs, in contrast to transgenic mice that carry the wildtype membrane Ig, were unable to induce the pre-B cell transition (Fig. 3) . Thus, even in the presence of the light chain, the mutant Igs were inactive, suggesting that contact with Igor and Ig{3 was the essential factor in the induction of the pre--B cell transition, irrespective of light chain expression and antigen receptor assembly. We have shown that the cytoplasmic domain of Igl3 was sufficient to activate the pre--B cell transition when expressed as part of a chimeric heavy chain that includes the membrane and external domains of the inactive YS:W Ix (19) . To examine the relative activities of Iga and Ig13 in the induction of the pre-B cell transition, we compared the previously reported IgJ] chimera and a similar construct expressing the cytoplasmic domain of Iga. Both of these chimeric immunoglobulins were coinjected with the cognate light chain gene described above, and at least two independent integrants were tested for each of these new strains. In contrast to the parental YS:W-IgM mutant Igs, expression of either the YS: VV-IgM: Ig0t or the YS : VV-IgM: Igl3 chimeras in the RAG-1 -/-background reconstituted the pre-B cell compartment (Fig. 3) . Bone marrow cells from RAG-1 -/-mice and the YS:W-IgM-transgenic RAG-1 -/ -mice had few detectable CD43-B220 + ceils, whereas the number of CD43-B220 + cells in YS:VVIgM : Igor-and YS : W -I g M : Ig]~ RAG-1-/--transgenic mice resembled that found in wild-type mice (Fig. 3) . Similar numbers o f p r e -B ceils were found in both sets o f Y S : VV-IgM:Igot-and Y S : W -I g M : I g~ R A G -1 -/ --t r a n sgenic strains. Further, the activation of the pre-B cell transition by Ig[3 in the chimeric heavy plus light chain R A G -1 -/ -transgenic mice was dependent on the presence of cytoplasmic tyrosine residues in Ig[3. Additional strains that carry the light chain and a chimeric heavy chain with a mutation oftyrosine 536 in the cytoplasmic domain of lg[3 resulted in an Ig that was no longer able to induce the pre-B cell transition (Fig. 3, right) .
Results

Expression of Transgenic
We conclude that the cytoplasmic domain of Iglx resembles that of Ig[3 in that it contains sufficient information to produce the signal that induces the pre-B cell transition.
Igol Induces Allelic Exclusion. To examine the role of Iglx in allelic exclusion and to compare the activities of Igo~ with Ig[3, we crossed all of the Ig-transgenic mice described above into BALB/c mice that were wild type for RAG-1. Bone marrow D N A samples were then tested for VDJ recombination by PCR. In agreement with previously published experiments, we found that a wild-type membrane IgM transgene was active in allelic exclusion, inhibiting V to DJ rearrangements but not D to J rearrangements (Fig.  4) . By contrast, heavy chains bearing the YS:VV mutation that interferes with the ability of b~ to pair with Igot-Ig[3 had no effect on gene rearrangements, even when they were assembled with the appropriate cognate light chain (Fig. 4) . Addition of the cytoplasmic domain of Igor to the inactive YS 9 VV Ig resulted in a chimera that inhibited V to DJ but not D to J recombination (Fig. 4) . Side-by-side comparisons of the YS : V V q g M : Igix-and YS : VV-IgM : Ig[3-expressing strains showed that the two were indistinguishable in their ability to inhibit recombination. Moreover, as was shown for strains that carry just the heavy chain (19) , inhibition of V to DJ rearrangements was dependent on the presence of cytoplasmic tyrosines in Ig[3 (Fig. 4) . Mice that carry the combination of the YS:VVIgM" Ig[3/Y-F and the light chain were unable to induce allelic exclusion (Fig. 4, right lane) .
We conclude that the cytoplasmic tail of Igix is sufficient to mediate inhibition of V to DJ recombination, and, therefore, with respect to allelic exclusion, the roles of the Ig0t and Ig[3 cytoplasmic domains are functionally equivalent.
D i s c u s s i o n
The B cell antigen receptor is a complex structure that has a number of diverse regulatory functions in both developing and mature B cells. This receptor is composed of two disulfide-linked heterodimers that are noncovalently associated on the plasma membrane (27) (28) (29) . The ligand-binding component, membrane IgM, has no signaling activity on its own but requires Ig0~ and Ig[3 to activate cellular responses such as tyrosine phosphorylation and Ca 2+ flux (15, 16, 18, 30) . Although the cytoplasmic domains of Iger and Ig13 are very different, both have a tyrosine-based SH2 target motif that is essential for signal transduction (15, 16, 30) . As first pointed out by Reth (31) , the YxxLxxxxxxxYxxL motif is also found in a number of other antigen receptor-associated proteins, including CD3 components and FcR~. In all cases studied to date, signal transduction by this class of receptors requires cross-linking (32) and is believed to involve activation of src family kinases. A second amplification step involves binding to syk family kinases (33), for which both Igci and Ig~ have similar affinities (34, 35) . However, the cytoplasmic domains of Ig0~ and Ig[3 have been shown to bind to different sets ofsrc kinases (14) , and they appear to have different signaling functions in transfected cell lines (15) (16) (17) . Given the diversity of cellular responses activated by membrane IgM, it has been proposed that individual receptor subunits may have independent physiologic functions.
W e have sought to resolve this issue by measuring the physiologic activities of Igor and Ig~ during the antigenindependent phase of B cell development. For this purpose we produced transgenic mice that express chimeric Ig molecules composed of the extracellular and transmembrane domains of a YS : VV mutant heavy chain and the cytoplasmic domains of Igor and Ig13. Light chains were coinjected with the Igor and IgI3 heavy chain transgenes to ensure the assembly of a membrane-bound receptor that could be expressed on the cell surface (Fig. 2, bottom) . Previous work has shown that YS:VV mutant hea W chains that do not contact Igot-Ig[3 cannot support the induction of the antigen-independent phase of B cell development (19) . Further, experiments with chimeric Igs showed that the cytoplasmic domain of Ig[3 was sufficient to trigger the pre-B cell transition and allelic exclusion by a mechanism that requires phosphorylation of the tyrosines of its A R H 1 motif (19) . The addition of the light chain in the experiments we report here did not diminish the activity of either the wildtype membrane-bound tx chain or the YS :VV-IgM: Ig[3 chimera in the induction of the pre-B cell transition or allelic exclusion (Figs. 3 and 4) . Conversely, the light chain transgene did not rescue the inactive Y S : V V -I g M or the tyrosine-mutant YS :W-IgM : Ig[3/Y-F chimera (Figs. 3  and 4) . Thus, Ig heavy and light chain assembly is neither required for nor does it significantly affect the antigenindependent events in the B cell pathway.
Analysis of the new chimeric molecules with the cytoplasmic tail of Igc~ showed that Igc~ is also sufficient to trigger the pro-to pre-B cell transition (Fig. 3) . In addition, signaling through the Igci chimera can lead to inhibition of recombination at endogenous heavy chain loci (Fig. 4) . Thus, IgoL resembles Ig[3 in that its cytoplasmic domain can trigger both of these antigen-independent events. Our resuits are similar to recent reports that examine this question in the context of the TCR (36, 37) . The TCR is more complex than the B cell receptor in that it is composed of two independent signaling modules (38-41) (the % B, module and the ~ dimer). Experiments with CD3~ -/-mice reconstituted with mutant transgenic ~ chains have shown that ~ is required for assembly of the TCR, but the signaling function of ~ is not required for T cell development (36) . In these mice, the % 8, ~ module was sufficient to produce CD4+CD8 -and CD4-CD8 + T cells in the complete absence of ~ signaling motifs (36) . Similarly, chimeric molecules composed of the external and transmembrane domains of the IL-2 receptor and the cytoplasmic domains of the CD3e or CD3~ tails have shown that in vivo cross-linking of either one was sufficient to mediate the transition from the double-negative to the double-positive cell stage (37) . Thus, in developing T cells, as in B cells, the physiologic activity of the antigen receptor homology 1-containing signaling proteins is redundant, and the presence of many molecules containing antigen receptor homology 1 motifs may simply function to amplify the signal. Nevertheless, these conclusions do not invalidate the suggestion that different signals might be delivered through the individual receptor-associated molecules, since only the early segments of the B and T cell pathways have been examined. There is, of course, a possibility that IgoL and Ig[3 have different functions in very early pro-B cells. Both of these proteins are expressed before VDJ recombination (42-44), and it has been suggested that they interact with a surrogate heavy chain to form a pro-B cell receptor (45). This receptor is thought to mediate activation of the transition from the very early pro-B cell to the later stages in development. It is also possible that events regulated by Ig in more mature B cells, such as deletion of autoreactive cells, silencing, or cellular activation, require orchestration of several signals, thus demanding different roles for IgoL and Ig~. In our transgenic mice, the heavy and light chain pair produces an anti-H2 k/k antibody, which results in the deletion ofautoreactive B cells in the appropriate genetic background (9) . Therefore, the system we have developed will allow us to test for differences between Igo~ and Ig~3 at stages subsequent to those of pre-B cell transition and allelic exclusion.
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